Details of the Drug

General Information of Drug (ID: DMVROVE)

Drug Name

EP0057

Synonyms

CRLX101

Indication

Disease Entry	ICD 11	Status	REF
Ovarian cancer	2C73	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Nanoparticle-drug conjugate

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04669002) Phase 2 Study to Evaluate the Safety & Efficacy of EP0057 in Combination With Olaparib in Advanced Ovarian Cancer Patients Who Have: Cohort 1 - Platinum Resistant Disease; Cohort 2 - Had at Least 1 Prior Line of Therapy Which Must Include at Least 1 Line of Platinum-based Chemotherapy Followed by PARP Inhibitor Maintenance. U.S.National Institutes of Health.